Stocktoria

Jade Biosciences, Inc. JBIO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-30

Jade Biosciences, Inc. statistics & valuation

Market cap$1.3B
P / B4.0×
Return on equity-38.3%
Return on capital-34.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-13.30% -40.60% -69.00% -38.30% 202020212022202320242025
Shares outstanding
243076 24.4M 24.7M 27.8M 28.6M 49.3M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-203.80% -13.10% -38.10% -59.30% -95.60% -36.40% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$1.87 -$2.10 -$2.87 -$2.44 -$3.19 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-36.4%-95.6%-59.3%-38.1%-13.1%-203.8%
Return on equity-38.3%148.8%-69.0%-40.6%-13.3%72.0%
Current ratio21.095.817.0416.9068.372.64

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.